Provider intakeProvider Documentation Completeness
Prior authorization slows down when required documentation is incomplete, late, or not policy-safe enough to trigger value.
Labs models complete prior-auth-ready evidence as an incentive-eligible milestone before the initial decision.
Delegated reviewDelegate UM SLA Incentives
Delegated UM quality is difficult to reward when contracts blur timely work with approvals, denials, savings, or utilization.
Labs models SLA timing, rationale completeness, audit evidence, and outcome-neutral incentive decisions.
Fulfillment pathSpecialty Rx Fulfillment SLA
Approved therapy can still stall when intake, clear-to-fill, shipment, exceptions, and delivery evidence live in separate handoffs.
Labs models fulfillment milestones so value moves only when contracted service levels are met.
Appeals readinessAppeals Packet Quality
Appeals readiness breaks when packets, policy citations, rationale, and evidence indexes are assembled late or rewarded by reversal outcomes.
Labs models complete, timely appeal packet readiness without tying incentives to appeal results.